Clinical Trials Update: May 25, 2006
Crohn's Disease Multiple Sclerosis Hip Replacement
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
This study will investigate the effectiveness of Remicade (infliximab) and Imuran (azathioprine) to treat moderate-to-severe Crohn's disease. Candidates at least 18 who have a CDAI score of >= 220 and <= 400 and are either corticosteroid dependent or being considered for at least their second course of oral systemic corticosteroids in the past 12 months may be eligible. People who have an inadequate response to 5-ASAs or budesonide also may qualify. Additional criteria apply.
The research site is in Asheville, N.C.
This study is evaluating an investigational medication to treat multiple sclerosis. You may qualify if you have been diagnosed with MS and experience either uncontrollable laughing and/or crying, or problems with your thinking and/or memory. All study medications and evaluations will be provided at no cost.
The research site is in La Jolla, Calif.
This research study will evaluate the effectiveness and safety of BAY 59-7939 in men and women aged 18 or older who are undergoing elective total hip replacement. Volunteers who do not have significant liver disease or conditions prohibiting bilateral venography may qualify.
The research site is in Aurora, Colo.
Copyright 2006 CenterWatch. All rights reserved.